MOSCOW, May 6. /TASS/. Vladislav Tretiak, the president of the Russian Ice Hockey Federation (RHF), said on Friday he had no information about alleged cases of banned substance meldonium abuse in the Russian-based Kontinental Hockey League (KHL).
Rene Fasel, the president of the International Ice Hockey Federation (IIHF), said earlier in the day that a single meldonium case was registered in KHL, but the level of the discovered doping substance was below the permitted level and, therefore, the suspension did not follow.
"I have no information about meldonium in KHL," Tretiak told journalists. "They say that there are no problems."
The World Anti-Doping Agency (WADA) announced on April 13 that the concentration of less than one microgram of meldonium in the body system of an athlete, whose doping tests were conducted before March 1, was acceptable.
The drug meldonium (mildronate) was included in the list of preparations banned by WADA from January 1, 2016. The presence of the meldonium substance in the athlete’s blood during and between competitions is a violation of anti-doping rules. The substance belongs to S4 class on the WADA blacklist (hormones and metabolic modulators).
Meldronate is a cardiovascular preparation freely available for purchase at pharmacies across Russia without doctor’s prescription.
Currently, 28 clubs are playing in the KHL, including Barys from Astana (Kazakhstan), Dinamo from Minsk (Belarus) and Dinamo from Riga (Latvia), Jokerit from Helsinki (Finland), Medvescak from Zagreb (Croatia) and Slovan from Bratislava (Slovakia).
The Kontinental Hockey League is an international league set up to promote ice hockey in Russia and other European and Asian states. KHL organizes matches of the Russian ice hockey championships.